|
By Benjamin V. Treadwell,
Ph.D.
Many find this time of year
very stressful, even to the point of deep depressive states. So it
seems appropriate in this month's Journal, particularly in light of
recent findings, to examine why exercise may help.
Most of us believe that
regular exercise is, for the most part, good for us physically,
maintaining cardiovascular health and preventing age-associated
diseases such as type II diabetes, osteoporosis and muscle atrophy.
Research (See May 2006
Juvenon Health Journal Moderate
Exercise: The Elixir of Mental Health.) has also suggested that
exercise can function as an antidepressant. In fact, investigators
have recently demonstrated that aerobic exercise may activate
biochemical pathways within the brain, physically altering its
chemistry to prevent depression.
Antidepressant
Delay
Antidepressant medications have been prescribed for decades, based
on the hypothesis that, by increasing the levels of specific
neurotransmitters, they counteract one of the underlying reasons
for the depressed state. The problem with this hypothesis is the
unusually long time (weeks to months) it takes for an
antidepressant to elicit a positive response in the
patient.
Observing that the
medication almost immediately (within days) elevates the
neurotransmitter levels, scientists questioned whether there are
additional factors involved. They found a correlation between
patients reporting a response and the appearance of specific brain
proteins, neurotrophic (nourishing to nervous tissue) factors, in
the antidepressant treated brain. But what stimulates these
proteins to appear?
Antidepressant
Alternative
In a very recent study with mice (See this month’s "Research
Update."), exercise activated a gene in specialized areas of the
brain to produce a protein known as VGF. VGF has previously been
described as a neurotrophic protein present in tiny vesicles within
brain cells. (Interestingly, this protein is also involved in
energy metabolism, strengthening neural circuits and transmitting
nerve impulses.)
Non-exercised, sedentary mice were lethargic
and scored poorly in activities associated with a sharp, active
mental state. In other words, they were "depressed." When a group
of these mice was placed in a cage with running wheels for a period
of four weeks, then tested for “depression” again, there was a
remarkable improvement in their mental sharpness and they were no
longer lethargic.
Hyper-sensitive
Hippocampus
Comparing the brains of the sedentary mice to the exercised mice,
researchers found a sharp increase in the amount of VGF present in
the hippocampus. In mammals, this area of the brain is involved in
processing memory and states of behavior, including
happiness/depression.
The hippocampus is
ultra-sensitive to emotional stress. Its cells can be permanently
damaged if the stress is chronic, resulting in deep depression.
Electric shock therapy, often used with patients who don’t respond
to medication, is one of the most effective treatments.
Interestingly, this treatment has recently been shown to stimulate
the synthesis of VGF protein, supporting the findings that VGF
protein is a key player in inhibiting depression.
There are additional
neurotrophic proteins, known as brain-derived neurotrophic factors
(BDNF), which appear to be involved in maintaining hippocampus
health and preventing depression. Researchers have also
demonstrated that levels of these proteins increase in the brains
of physically active animals as compared to sedentary control
animals.
V.I.P.
VGF
Identifying the precise role VGF protein plays in
reducing/preventing depression is a work in progress. However, the
investigators strongly suggest that the known activities ascribed
to VGF, including, energy production, neuroprotection and synaptic
plasticity (the capacity of a neuron to increase its firing
strength), are most likely critical components. In fact,
psychological stress, the precursor to depression, counters these
activities, presumably by depleting the brain of VGF.
Improving Your
Odds
Estimations are that 16 out of 100 individuals in the United States
experience depression on a regular basis. Exercise could have a
significant effect on improving this number. Recent studies,
particularly the very recent work discussed here, suggest that
exercise significantly improves the health of at least one
important brain center, the hippocampus, involved in processing
memory, behavior and happiness.
Even though the exact
mechanisms have yet to be identified, the many other known benefits
of exercise — maintaining cardiovascular health, preventing
age-associated diseases, reducing stress — already make it a good
bet. Take home message: put daily aerobic exercise at the top of
your New Year’s resolutions.
|
|
In an advance online
publication by "Nature Medicine," researchers, from the
Yale University Department of Psychiatry and New York’s Mount Sinai
School of Medicine Department of Neuroscience, discuss their study
of the mechanisms underlying the antidepressant effects of
exercise.
Specifically, the group
examined the relationship between aerobic exercise and the
activation of an antidepressant gene in the brains of mice. This
seminal investigation identified a new role for the
exercise-stimulated synthesis of the neurotrophic peptide VGF. The
results strongly imply that VGF functions as an antidepressant in
the hippocampus, the area of the brain associated with emotional
states.
This work is provocative
for two important reasons. First, it demonstrates that regular
exercise promotes mental health in animals, implying the same for
humans. Second, it presents a new potential therapeutic target for
the development of more effective antidepressant drugs.
Engineering these drugs to
increase the levels of the neurotrophic peptide VGF could decrease
the time required for antidepressants to take effect. Additionally,
VGF-targeted drugs may be far more potent in attenuating the
depressed condition than the antidepressants on the market
today.
Click here to read the full abstract.
"Antidepressant actions of
the exercise-regulated gene VGF"
Nature Medicine 13, 1476 - 1482
(2007)
This Research Update
column highlights articles related to recent scientific inquiry
into the process of human aging. It is not intended to promote any
specific ingredient, regimen, or use and should not be construed as
evidence of the safety, effectiveness, or intended uses of the
Juvenon product. The Juvenon label should be consulted for intended
uses and appropriate directions for use of the
product.
|